Pituitary adenoma and apoplexy during GnRH agonist treatment for IVF - case report

Gynecol Endocrinol. 2020 Jun;36(6):561-563. doi: 10.1080/09513590.2019.1706086. Epub 2019 Dec 23.

Abstract

In vitro fertilization is commonly used for treating infertility. One stage of this process is controlled hyperstimulation of the ovaries, achieved by administering gonadotropins. There are several stimulation protocols utilized that increase the number of ovarian follicles during IVF. The most common protocol employs desensitization - the inhibition of follicle-stimulating hormone and luteinizing hormone secretion by the pituitary gland. This is achieved by administering a gonadotropin-releasing hormone (GnRH) analog that is agonistic for the GnRH receptor. However the use of a this drug during therapy carries a risk of complications. This case report deals with a rare case of a woman who underwent pituitary tumor growth as a result of the treatment of GnRH analog.

Keywords: GnRH analogs; In vitro fertilization; gonadotropinoma; stroke of the pituitary gland.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / chemically induced*
  • Adenoma / diagnosis
  • Adenoma / surgery
  • Adult
  • Emergency Treatment
  • Female
  • Fertilization in Vitro / adverse effects
  • Fertilization in Vitro / methods
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Neurosurgical Procedures
  • Pituitary Apoplexy / chemically induced*
  • Pituitary Apoplexy / diagnosis
  • Pituitary Apoplexy / surgery
  • Pituitary Gland / diagnostic imaging
  • Pituitary Gland / drug effects
  • Pituitary Gland / pathology
  • Pituitary Gland / surgery
  • Pituitary Neoplasms / chemically induced*
  • Pituitary Neoplasms / diagnosis
  • Pituitary Neoplasms / surgery
  • Triptorelin Pamoate / adverse effects*
  • Triptorelin Pamoate / therapeutic use

Substances

  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone